The 26 references in paper A. Grazhdantseva A., G. Sivolobova F., M. Major , E. Chub V., A. Shvalov N., P. Yudin V., S. Netesov V., V. Loktev B., G. Kochneva V., А. Гражданцева А., Г. Сиволобова Ф., M. Major, Е. Чуб В., А. Швалов Н., П. Юдин В., С. Нетесов В., В. Локтев Б., Г. Кочнева В. (2014) “ПОЛНОРАЗМЕРНЫЙ ПЕПТИДНЫЙ АНАЛИЗ АНТИГЕННОГО ПРОФИЛЯ ПОВЕРХНОСТНЫХ БЕЛКОВ СИБИРСКИХ ИЗОЛЯТОВ ВИРУСА ГЕПАТИТА C // FULL-LENGTH PEPTIDE ASSAY OF ANTIGENIC PROFILE OF ENVELOPE PROTEINS FROM SIBERIAN ISOLATES OF HEPATITIS C VIRUS” / spz:neicon:mimmun:y:2010:i:2:p:115-124

1
Шустов А.В., Кочнева Г.В., Сиволобова Г.Ф., Гражданцева А.А., Гаврилова И.В., Нестеров А.Е., Стрельцова М.А., Пальцев А.И., Локтев А.В., Максютов А.З., Акинфеева Л.А., Торшин В.П., West T.E., Ryder R.W., Онищенко Г.Г. Частота встречаемости маркеров гепатита С и факторы риска у персонала больниц Новосибирской области // Журн. микробиол. эпидемиол. и иммунобиологии (ЖМЭИ). – 2002. – T. 2. – C. 26-32.
(check this in PDF content)
2
Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection // Nature. – 2005. – Vol. 436. – P. 946-952.
(check this in PDF content)
3
Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes // Semin Liver Dis. – 1995. – Vol. 15. – P. 41-63.
(check this in PDF content)
4
Carlos M.P., Yamamura Y., Vu Q., Conzen K., Anderson D.E., Torres J.V. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b // Clin. Immunol. – 2004. – Vol. 111. – P. 22-27.
(check this in PDF content)
5
Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H., Purcell R. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein // Proc. Natl. Acad. Sci. USA. – 1996. – Vol. 93. – P. 15394-15399.
(check this in PDF content)
6
Gotto J., Dusheiko G.M. Hepatitis C and treatment with pegylated interferon and ribavirin // Int. J. Biochem. Cell Biol. – 2004. – Vol. 36, N 10. – P. 1874-1877.
(check this in PDF content)
7
Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzymelinked immunosorbent assay using synthetic peptides as antigens // J. Clin. Microbiol. – 1993. – Vol. 31. – P. 936-940.
(check this in PDF content)
8
Keck Z-Y., Sung V.M.H., Perkins S., Rowe J., Paul S., Liang T.J., Lai M.M.C., Foung S.K.H. Human monoclonal antibody to hepatitis C Virus E1 glycoprotein that blocks virus attachment and viral infectivity // J. Virol. – 2004. – Vol. 78, N 13. – P. 7257-7263.
(check this in PDF content)
9
Lecnmann M., Ihlenfeldt H.G., Braunschweiger I., Gierls G., Jung G., Matz B., Kaiser R., Sauberbruch T., Spengler U. T and B Cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia // Hepatology. – 1996. – Vol. 24, N 4. – P. 790-795.
(check this in PDF content)
10
Martinez-Donato G., Duenas-Carrera S., Alvarez-Lajonchere L., Morales J., AcostaRivero N., Martínez E., Viña A., Guerra I., Prez A., Musacchio A., García J., Reyes O., Garay H.E., González L.J., Alvarez J.C., Soria Y. Antigenicity and immunogenecity of the hepatitis C virus envelope E2 protein // Biotecnologia Aplicada. – 2006. – Vol. 23, N 1. – P. 60-63.
(check this in PDF content)
11
Meunier J.C., Russell R.S., Goossens V., Priem S., Walter H., Depla E., Union A., Faulk K.N., Bukh J., Emerson S.U., Purcell R.H. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus // J. Virol. – 2008. – Vol. 82, N 2. – P. 966-973.
(check this in PDF content)
12
Olenina L.V., Nikolaeva L.I., Sobolev B.N., Blokhina N.P., Archakov A.I., Kolesanova E.F. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins // J. Viral. Hepat. – 2002. – Vol. 9. – P. 174-182.
(check this in PDF content)
13
Perotti M., Mancini N., Diotti R.A., Tarr A.W., Ball J.K., Owsianka A., Adair R., Patel A.H., Clementi M., Burioni R. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein // J. Virol. – 2008. – Vol. 82, N 2. – P. 1047-1052.
(check this in PDF content)
14
Petit M.-A., Jolivet-Reynaud C., Peronnet E., Michal Y., Tre'po C. Mapping of a conformational epitope shared between E1 and E2 on the serumderived human hepatitis C virus envelope // J. Biol. Chem. – 2003. – Vol. 278, N 45. – P. 44385-44392.
(check this in PDF content)
15
Petrik J., Alexander G.J.M., Pearson G., Allain J.P. Reactivity of synthetic peptides representing selected sections of hepatitis C virus Core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma // J. Med. Virol. – 1997. – Vol. 51. – P. 67-79.
(check this in PDF content)
16
Sallberg M., Ruden U., Wahren B., Magnius L.O. Antigenic regions within the hepatitis C virus envelope 1 and structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein // Clin. Exp. Imunol. – 1993. – Vol. 91. – P. 489-494.
(check this in PDF content)
17
Seeff L.B. Natural history of chronic hepatitis C // Hepatology. – 2002. – Vol. 36, N 5. – P. 35-46.
(check this in PDF content)
18
Shimizu Y.K., Igarashi H., Kiyohara T. A hyperimmune constructs against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures // Virol. – 1996. – Vol. 223. – P. 409-412.
(check this in PDF content)
19
Simmonds P., Rose K.A., Graham S., Chan S.W., McOmish F., Dow B.C., Follet E.A., Yap P.L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 // J. Clin. Microbiol. – 1993. – Vol. 31. – P. 1493-1503.
(check this in PDF content)
20
Simmonds P. The origin and evolution of hepatitis viruses in humans // J. Gen. Virol. – 2001. – Vol. 82. – P. 693-712.
(check this in PDF content)
21
Tarr A.W., Owsianka A.M., Timms J.M., Patrick McClure C., Brown R.J.P., Hickling T.P., Pietschmann T., Bartenschlager R., Patel A.H., Ball J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 // Hepatology. – 2006. – Vol. 43, N 3. – P. 592-601.
(check this in PDF content)
22
Tarr A.W., Owsianka A.M., Szwejk A., Ball J.K., Patel A.H. Cloning, expression and functional analysis of patient-derived hepatitis C virus glycoproteins // Methods Mol. Biol. – 2007. – Vol. 379. – P. 177-197.
(check this in PDF content)
23
Tarr A.W., Owsianka A.M., Jayaraj D., Brown R.J.P., Hickling T.P., Irving W.L., Patel A.H., Ball J.K. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 // J. Gen. Virol. – 2007. – Vol. 88. – Р. 2991-3001.
(check this in PDF content)
24
Zhang Z.-X., Sonnerborg A., Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein // Clin. Exp. Immunol. – 1994. – Vol. 98. – P. 382-387.
(check this in PDF content)
25
Zang P., Wu C.G., Mihalik K., VirataTheimer M.L., Yu M.W., Alter H.J., Feinstone S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma // Proc. Natl. Acad. Sci. USA. – 2007. – Vol. 104, N 20. – P. 8449-8454.
(check this in PDF content)
26
Zhang P., Zhong L., Struble E. B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-
(check this in PDF content)